cholesterol assay kit Search Results


86
Nanjing Jiancheng Bioengineering Research Institute Co Ltd cholesterol test kit
Cholesterol Test Kit, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc12499452-440-10-14?v=Nanjing+Jiancheng+Bioengineering+Research+Institute+Co+Ltd
Average 86 stars, based on 1 article reviews
cholesterol test kit - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

95
Elabscience Biotechnology hdl c
Hdl C, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pm41372250-142-7-19?v=Elabscience+Biotechnology
Average 95 stars, based on 1 article reviews
hdl c - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

95
Elabscience Biotechnology ldl c assay kit
Key Resources Table
Ldl C Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc11693944-26-0-4?v=Elabscience+Biotechnology
Average 95 stars, based on 1 article reviews
ldl c assay kit - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Elabscience Biotechnology assay kits
Key Resources Table
Assay Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/10__1016_slash_j__jff__2023__105774-96-17-19?v=Elabscience+Biotechnology
Average 93 stars, based on 1 article reviews
assay kits - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology cholesteryl ester fluorometric assay kit
Key Resources Table
Cholesteryl Ester Fluorometric Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc09658088-42-8-13?v=Elabscience+Biotechnology
Average 93 stars, based on 1 article reviews
cholesteryl ester fluorometric assay kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Danaher Inc cholesterol assay kit
T2D contributes to therapy resistance in PDAC. Schematic diagram of the experimental setup. Arrows indicate Streptozotocin (STZ) administration and fecal matter collection. C1, C2, C3, C4 refer to control groups that do not receive STZ or high fat diet D1, D2, D3, D4 refer to animals receiving STZ and put on high fat diet. C4 and D4 groups were further split into C4′ and D4′ to indicate groups that received Gem/Pac therapy ( a ). Blood glucose ( b ) and blood <t>cholesterol</t> ( c ) was measured at the end of 1 month to validate hyperglycemia and T2D onset in animals. After tumor implantation and 1 month of Gem/Pac, T2D group animals did not show any significant change in tumor volume ( e ) or weight ( f ), while the control tumors responded to the standard of care. *Indicates p value = 0.05
Cholesterol Assay Kit, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc07092523-87-10-13?v=Danaher+Inc
Average 93 stars, based on 1 article reviews
cholesterol assay kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

95
Elabscience Biotechnology tc colorimetric assay kit
T2D contributes to therapy resistance in PDAC. Schematic diagram of the experimental setup. Arrows indicate Streptozotocin (STZ) administration and fecal matter collection. C1, C2, C3, C4 refer to control groups that do not receive STZ or high fat diet D1, D2, D3, D4 refer to animals receiving STZ and put on high fat diet. C4 and D4 groups were further split into C4′ and D4′ to indicate groups that received Gem/Pac therapy ( a ). Blood glucose ( b ) and blood <t>cholesterol</t> ( c ) was measured at the end of 1 month to validate hyperglycemia and T2D onset in animals. After tumor implantation and 1 month of Gem/Pac, T2D group animals did not show any significant change in tumor volume ( e ) or weight ( f ), while the control tumors responded to the standard of care. *Indicates p value = 0.05
Tc Colorimetric Assay Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pm36364926-64-15-19?v=Elabscience+Biotechnology
Average 95 stars, based on 1 article reviews
tc colorimetric assay kit - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

93
Cusabio mouse high density lipoprotein cholesterol hdl c elisa kit
T2D contributes to therapy resistance in PDAC. Schematic diagram of the experimental setup. Arrows indicate Streptozotocin (STZ) administration and fecal matter collection. C1, C2, C3, C4 refer to control groups that do not receive STZ or high fat diet D1, D2, D3, D4 refer to animals receiving STZ and put on high fat diet. C4 and D4 groups were further split into C4′ and D4′ to indicate groups that received Gem/Pac therapy ( a ). Blood glucose ( b ) and blood <t>cholesterol</t> ( c ) was measured at the end of 1 month to validate hyperglycemia and T2D onset in animals. After tumor implantation and 1 month of Gem/Pac, T2D group animals did not show any significant change in tumor volume ( e ) or weight ( f ), while the control tumors responded to the standard of care. *Indicates p value = 0.05
Mouse High Density Lipoprotein Cholesterol Hdl C Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/10__1515_slash_med___2022___0576-49-29-39?v=Cusabio
Average 93 stars, based on 1 article reviews
mouse high density lipoprotein cholesterol hdl c elisa kit - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

85
Cusabio immunosorbent assay
T2D contributes to therapy resistance in PDAC. Schematic diagram of the experimental setup. Arrows indicate Streptozotocin (STZ) administration and fecal matter collection. C1, C2, C3, C4 refer to control groups that do not receive STZ or high fat diet D1, D2, D3, D4 refer to animals receiving STZ and put on high fat diet. C4 and D4 groups were further split into C4′ and D4′ to indicate groups that received Gem/Pac therapy ( a ). Blood glucose ( b ) and blood <t>cholesterol</t> ( c ) was measured at the end of 1 month to validate hyperglycemia and T2D onset in animals. After tumor implantation and 1 month of Gem/Pac, T2D group animals did not show any significant change in tumor volume ( e ) or weight ( f ), while the control tumors responded to the standard of care. *Indicates p value = 0.05
Immunosorbent Assay, supplied by Cusabio, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc03706860-45-26-31?v=Cusabio
Average 85 stars, based on 1 article reviews
immunosorbent assay - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

93
Novus Biologicals high density lipoprotein cholesterol hdl c
Effect of fetal Intralipid infusion on serum metabolic parameters. (A) Serum glucose concentrations. (B) Serum triglyceride (TG) concentrations. (C) Serum total <t>cholesterol</t> concentrations. (D) Serum low‐density <t>lipoprotein</t> cholesterol (LDL‐C) concentrations. (E) Serum high‐density cholesterol (HDL‐C) concentration. (Control group: N = 2F, 6M; Intralipid‐treated group: N = 6F, 3M; data are presented as mean ± SD; * p < 0.05, ** p < 0.01).
High Density Lipoprotein Cholesterol Hdl C, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc12571146-68-8-29?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
high density lipoprotein cholesterol hdl c - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Cusabio rat ldl c elisa kit
Fig. 1 L. reuteri supplementation ameliorates dyslipidemia in constant darkness rats. a Timeline depicting the treatments of darkness and L. reuteri in different groups of the L. reuteri-treated rat model. b Representative estrous cycles. M, metestrus; D, diestrus; P, proestrus; E, estrus. c Quantitative analysis of estrous cycles. d Representative hematoxylin and eosin staining of ovaries. Asterisk stands for corpus luteum. Scale bar: 200 μm. e–g Serum concentrations of LH/FSH ratio (e), testosterone (f), and SHBG (g) detected by <t>ELISA.</t> h Body weight changes. i Representative Oil Red O staining of livers. Scale bar: 50 μm and 25 μm. j Representative images of liver ultrastructure detected by transmission electron microscope. Scale bar: 40 μm and 1 μm. k Hepatic contents of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. l Serum concentrations of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. Statistical analysis was performed with one-way ANOVA followed by Newman–Keuls multiple comparison test. n = 8 per group. Data present means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
Rat Ldl C Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pm37422471-359-33-38?v=Cusabio
Average 91 stars, based on 1 article reviews
rat ldl c elisa kit - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
Cusabio ldl cholesterol
Fig. 1 L. reuteri supplementation ameliorates dyslipidemia in constant darkness rats. a Timeline depicting the treatments of darkness and L. reuteri in different groups of the L. reuteri-treated rat model. b Representative estrous cycles. M, metestrus; D, diestrus; P, proestrus; E, estrus. c Quantitative analysis of estrous cycles. d Representative hematoxylin and eosin staining of ovaries. Asterisk stands for corpus luteum. Scale bar: 200 μm. e–g Serum concentrations of LH/FSH ratio (e), testosterone (f), and SHBG (g) detected by <t>ELISA.</t> h Body weight changes. i Representative Oil Red O staining of livers. Scale bar: 50 μm and 25 μm. j Representative images of liver ultrastructure detected by transmission electron microscope. Scale bar: 40 μm and 1 μm. k Hepatic contents of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. l Serum concentrations of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. Statistical analysis was performed with one-way ANOVA followed by Newman–Keuls multiple comparison test. n = 8 per group. Data present means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
Ldl Cholesterol, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cholesterol+assay+kit/pmc08837240-81-28-31?v=Cusabio
Average 90 stars, based on 1 article reviews
ldl cholesterol - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Key Resources Table

Journal: Drug Design, Development and Therapy

Article Title: Baolier Capsule’s Secret Weapon: Piperine Boosts Cholesterol Excretion to Combat Atherosclerosis

doi: 10.2147/DDDT.S499598

Figure Lengend Snippet: Key Resources Table

Article Snippet: LDL-C assay kit , Elabscience , E-BC-K205-M.

Techniques: Control, shRNA, Sequencing, Staining, Fluorescence, Microscopy, AST Assay, Phospholipid Assay, Mass Spectrometry

T2D contributes to therapy resistance in PDAC. Schematic diagram of the experimental setup. Arrows indicate Streptozotocin (STZ) administration and fecal matter collection. C1, C2, C3, C4 refer to control groups that do not receive STZ or high fat diet D1, D2, D3, D4 refer to animals receiving STZ and put on high fat diet. C4 and D4 groups were further split into C4′ and D4′ to indicate groups that received Gem/Pac therapy ( a ). Blood glucose ( b ) and blood cholesterol ( c ) was measured at the end of 1 month to validate hyperglycemia and T2D onset in animals. After tumor implantation and 1 month of Gem/Pac, T2D group animals did not show any significant change in tumor volume ( e ) or weight ( f ), while the control tumors responded to the standard of care. *Indicates p value = 0.05

Journal: Microbial Cell Factories

Article Title: Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma

doi: 10.1186/s12934-020-01330-3

Figure Lengend Snippet: T2D contributes to therapy resistance in PDAC. Schematic diagram of the experimental setup. Arrows indicate Streptozotocin (STZ) administration and fecal matter collection. C1, C2, C3, C4 refer to control groups that do not receive STZ or high fat diet D1, D2, D3, D4 refer to animals receiving STZ and put on high fat diet. C4 and D4 groups were further split into C4′ and D4′ to indicate groups that received Gem/Pac therapy ( a ). Blood glucose ( b ) and blood cholesterol ( c ) was measured at the end of 1 month to validate hyperglycemia and T2D onset in animals. After tumor implantation and 1 month of Gem/Pac, T2D group animals did not show any significant change in tumor volume ( e ) or weight ( f ), while the control tumors responded to the standard of care. *Indicates p value = 0.05

Article Snippet: Measurement of total cholesterol from mice serum were performed using cholesterol assay kit (Abcam) according to the manufacturer’s instructions.

Techniques: Control, Tumor Implantation

Effect of fetal Intralipid infusion on serum metabolic parameters. (A) Serum glucose concentrations. (B) Serum triglyceride (TG) concentrations. (C) Serum total cholesterol concentrations. (D) Serum low‐density lipoprotein cholesterol (LDL‐C) concentrations. (E) Serum high‐density cholesterol (HDL‐C) concentration. (Control group: N = 2F, 6M; Intralipid‐treated group: N = 6F, 3M; data are presented as mean ± SD; * p < 0.05, ** p < 0.01).

Journal: The FASEB Journal

Article Title: Intralipid Infusion to Fetal Sheep ( Ovis aries ) Promotes Differentiation and Lipid Accumulation of Adipose Tissues

doi: 10.1096/fj.202502000R

Figure Lengend Snippet: Effect of fetal Intralipid infusion on serum metabolic parameters. (A) Serum glucose concentrations. (B) Serum triglyceride (TG) concentrations. (C) Serum total cholesterol concentrations. (D) Serum low‐density lipoprotein cholesterol (LDL‐C) concentrations. (E) Serum high‐density cholesterol (HDL‐C) concentration. (Control group: N = 2F, 6M; Intralipid‐treated group: N = 6F, 3M; data are presented as mean ± SD; * p < 0.05, ** p < 0.01).

Article Snippet: Measurement of serum biochemical parameters, including triglycerides (TG), high‐density lipoprotein cholesterol (HDL‐C), and low‐density lipoprotein cholesterol (LDL‐C), was performed according to the manufacturers' instructions using commercially available assay kits (Novus Biologicals, Centennial, CO, USA; catalog numbers NBP3‐24542, NBP3‐25823, and NBP3‐25881, respectively).

Techniques: Concentration Assay, Control

Fig. 1 L. reuteri supplementation ameliorates dyslipidemia in constant darkness rats. a Timeline depicting the treatments of darkness and L. reuteri in different groups of the L. reuteri-treated rat model. b Representative estrous cycles. M, metestrus; D, diestrus; P, proestrus; E, estrus. c Quantitative analysis of estrous cycles. d Representative hematoxylin and eosin staining of ovaries. Asterisk stands for corpus luteum. Scale bar: 200 μm. e–g Serum concentrations of LH/FSH ratio (e), testosterone (f), and SHBG (g) detected by ELISA. h Body weight changes. i Representative Oil Red O staining of livers. Scale bar: 50 μm and 25 μm. j Representative images of liver ultrastructure detected by transmission electron microscope. Scale bar: 40 μm and 1 μm. k Hepatic contents of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. l Serum concentrations of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. Statistical analysis was performed with one-way ANOVA followed by Newman–Keuls multiple comparison test. n = 8 per group. Data present means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.

Journal: NPJ biofilms and microbiomes

Article Title: Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling.

doi: 10.1038/s41522-023-00415-2

Figure Lengend Snippet: Fig. 1 L. reuteri supplementation ameliorates dyslipidemia in constant darkness rats. a Timeline depicting the treatments of darkness and L. reuteri in different groups of the L. reuteri-treated rat model. b Representative estrous cycles. M, metestrus; D, diestrus; P, proestrus; E, estrus. c Quantitative analysis of estrous cycles. d Representative hematoxylin and eosin staining of ovaries. Asterisk stands for corpus luteum. Scale bar: 200 μm. e–g Serum concentrations of LH/FSH ratio (e), testosterone (f), and SHBG (g) detected by ELISA. h Body weight changes. i Representative Oil Red O staining of livers. Scale bar: 50 μm and 25 μm. j Representative images of liver ultrastructure detected by transmission electron microscope. Scale bar: 40 μm and 1 μm. k Hepatic contents of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. l Serum concentrations of TG, CHOL, HDL-C, LDL-C, and NEFA detected by ELISA. Statistical analysis was performed with one-way ANOVA followed by Newman–Keuls multiple comparison test. n = 8 per group. Data present means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.

Article Snippet: The concentrations of TG, total CHOL, HDL-C, LDL-C, and NEFA in rat sera and liver tissues were detected using Triglyceride Quantification Assay Kit (#ab65336, Abcam), HDL and LDL/VLDL Cholesterol Assay Kit (#ab65390, Abcam), Rat LDL-C ELISA Kit (#CSB-E16561r, Cusabio, Wuhan, China), and Free Fatty Acid Quantification Assay Kit (#ab65341, Abcam), respectively.

Techniques: Staining, Enzyme-linked Immunosorbent Assay, Transmission Assay, Microscopy, Comparison

Fig. 2 Liver transcriptome analysis of L. reuteri-treated darkness rats. Heatmaps displaying 36 highly expressed genes (a) and 76 lowly expressed genes (b) in the liver of darkness rats compared with control and DL.reuteri rats through DEG analysis using Ballgown software (| fold change | > 0.6 in the log2 ratio value, raw P < 0.05). c Top terms from GO analysis (above) and terms from KEGG analysis (below) of the 112 differential genes in the DEG analysis. The P values of GO and KEGG analyses were determined on the DAVID website. d Visualization of the top GO and KEGG terms related with lipid metabolism and circadian rhythm in the DEG analysis. e Spearman rank correlations between module eigengenes (ME) and clinical biochemical index in the WGCNA analysis (|ρ | > 0.3, *P < 0.05). f Visualization of the top GO and KEGG terms related with lipid metabolism and circadian rhythm of purple module genes (102) in the WGCNA analysis. Circle, genes; Square, KEGG terms; Hexagon, GO terms. The bigger the square or hexagon, the more genes involved. g Crosstalk among different groups of genes identified the possible target genes taking essential roles in the lipid metabolism of L. reuteri-treated darkness rats. h mRNA abundances of Galr1, Galr2, Nr1d1, Nr1d2, Insig2, Srebf1, Lxra, and Rxra in rat liver detected by qPCR. β-Actin was used as a loading control for qPCR analyses. i Serum galanin concentration detected by ELISA. Statistical analysis (h, i) was performed with one-way ANOVA followed by Newman–Keuls multiple comparison test. n = 8 per group. Data present means ± SEM. *P < 0.05, **P < 0.01.

Journal: NPJ biofilms and microbiomes

Article Title: Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and GALR1 signaling.

doi: 10.1038/s41522-023-00415-2

Figure Lengend Snippet: Fig. 2 Liver transcriptome analysis of L. reuteri-treated darkness rats. Heatmaps displaying 36 highly expressed genes (a) and 76 lowly expressed genes (b) in the liver of darkness rats compared with control and DL.reuteri rats through DEG analysis using Ballgown software (| fold change | > 0.6 in the log2 ratio value, raw P < 0.05). c Top terms from GO analysis (above) and terms from KEGG analysis (below) of the 112 differential genes in the DEG analysis. The P values of GO and KEGG analyses were determined on the DAVID website. d Visualization of the top GO and KEGG terms related with lipid metabolism and circadian rhythm in the DEG analysis. e Spearman rank correlations between module eigengenes (ME) and clinical biochemical index in the WGCNA analysis (|ρ | > 0.3, *P < 0.05). f Visualization of the top GO and KEGG terms related with lipid metabolism and circadian rhythm of purple module genes (102) in the WGCNA analysis. Circle, genes; Square, KEGG terms; Hexagon, GO terms. The bigger the square or hexagon, the more genes involved. g Crosstalk among different groups of genes identified the possible target genes taking essential roles in the lipid metabolism of L. reuteri-treated darkness rats. h mRNA abundances of Galr1, Galr2, Nr1d1, Nr1d2, Insig2, Srebf1, Lxra, and Rxra in rat liver detected by qPCR. β-Actin was used as a loading control for qPCR analyses. i Serum galanin concentration detected by ELISA. Statistical analysis (h, i) was performed with one-way ANOVA followed by Newman–Keuls multiple comparison test. n = 8 per group. Data present means ± SEM. *P < 0.05, **P < 0.01.

Article Snippet: The concentrations of TG, total CHOL, HDL-C, LDL-C, and NEFA in rat sera and liver tissues were detected using Triglyceride Quantification Assay Kit (#ab65336, Abcam), HDL and LDL/VLDL Cholesterol Assay Kit (#ab65390, Abcam), Rat LDL-C ELISA Kit (#CSB-E16561r, Cusabio, Wuhan, China), and Free Fatty Acid Quantification Assay Kit (#ab65341, Abcam), respectively.

Techniques: Control, Software, Concentration Assay, Enzyme-linked Immunosorbent Assay, Comparison